Tuberculosis drug discovery in the post‐post‐genomic era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuberculosis drug discovery in the post‐post‐genomic era

Published:2014-01-08 Issue:2 Volume:6 Page:158-168
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Lechartier Benoit¹,Rybniker Jan¹²,Zumla Alimuddin³,Cole Stewart T¹

Affiliation:

1. Ecole Polytechnique Fédérale de Lausanne Global Health Institute Lausanne Switzerland

2. 1st Department of Internal Medicine University of Cologne Cologne Germany

3. Division of Infection and Immunity University College London and UCLHospitals NHS Foundation Trust London UK

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201201772

Reference73 articles.

1. Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening

2. Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

3. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

4. inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis

5. EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression;ACS Infectious Diseases;2024-07-22

2. Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis;Scientific Reports;2024-05-28

3. Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles;Life Science Alliance;2024-05-14

4. Uncovering the potentiality of quinazoline derivatives against Pseudomonas aeruginosa with antimicrobial synergy and SAR analysis;The Journal of Antibiotics;2024-03-21

5. Structure-based drug design and characterization of novel pyrazine hydrazinylidene derivatives with a benzenesulfonate scaffold as noncovalent inhibitors of DprE1 tor tuberculosis treatment;Molecular Diversity;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3